30 results
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
of the trials will become available, and our research and development programs;
the potential for COVID-19 or other pandemic, epidemic or outbreak
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
;
the potential for COVID-19 or other pandemic, epidemic or outbreak of an infectious disease, to disrupt our business plans, product development
424B3
wai21td0nhxg lxq
15 Sep 23
Prospectus supplement
6:31am
S-4/A
0pyz 3xjwob8r0dx5u
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
0rffqh pm6dd7nopoa
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
p1qjm0s8f5n 7ht
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
n632t1fpj7x8l an9pc
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
S-3
e5bexa6d
15 Aug 22
Shelf registration
5:06pm
8-K
7ys8rm70m
30 Jun 22
Other Events
4:54pm
8-K
EX-99.1
4v7tsdi
30 Jun 22
Other Events
4:54pm